World News: 19:01 GMT Wednesday 11th July 2018. [Levi & Korsinsky, LLP via Globe Newswire via SPi World News]
NEW YORK, July 11, 2018 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court; further details about the cases can be found at the links provided.
According to the complaint, Prothena allegedly made materially false and/or misleading statements and/or failed to disclose that: relevant trial data showed that Prothena’s antibody NEOD001, designed to treat amyloid light chain amyloidosis (“AL amyloidosis”), was not an effective treatment; the Company made misleading comparisons of NEOD001’s “best response” rates against certain prior studies; and the Company touted Prothena’s ongoing Phase 1/2 study of NEOD001 as providing a strong basis for late-stage Phase 2b and Phase 3 studies of NEOD001, even though the full Phase 1/2 study data demonstrated that NEOD001 was not an effective treatment.
To learn more about the Prothena class action go to: .
According to the complaint, A10 had issues with its internal controls that required an Audit Committee investigation; A10's revenues since the fourth quarter of 2015 were false due to improper revenue recognition, which prompted an investigation by the Company’s Audit Committee; and as a result, Defendants' public statements were materially false and misleading at all relevant times.
To learn more about the A10 class action go to: .
You have until the lead plaintiff deadlines to request the court appoint as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:Levi & Korsinsky, LLPJoseph E. Levi, Esq.30 Broad Street - 24th FloorNew York, NY 10004Tel: (212) 363-7500Toll Free: (877) 363-5972Fax: (212) 363-7171
More news and information about Levi & Korsinsky, LLP
Globe Newswire: 19:01 GMT Wednesday 11th July 2018
Published: 2018-07-11T19:01:22.
Search for other references to "class" on SPi News
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us